cidrap.umn.edu
63%
555
News Scan for Aug 15, 2022
Following the Food and Drug Administration (FDA) emergency use authorization (EUA) of the Novavax COVID-19 vaccine last month for the primary vaccine series, the company announced today that it has applied for an EUA for the vaccine to also be used as a booster in adults ages 18 and older.In an announcement today, Novavax said if authorized, the vaccine